NipahVR: a resource of multi-targeted putative therapeutics and epitopes for the Nipah virus
Citations Over TimeTop 16% of 2020 papers
Abstract
Nipah virus (NiV) is an emerging and priority pathogen from the Paramyxoviridae family with a high fatality rate. It causes various diseases such as respiratory ailments and encephalitis and poses a great threat to humans and livestock. Despite various efforts, there is no approved antiviral treatment available. Therefore, to expedite and assist the research, we have developed an integrative resource NipahVR (http://bioinfo.imtech.res.in/manojk/nipahvr/) for the multi-targeted putative therapeutics and epitopes for NiV. It is structured into different sections, i.e. genomes, codon usage, phylogenomics, molecular diagnostic primers, therapeutics (siRNAs, sgRNAs, miRNAs) and vaccine epitopes (B-cell, CTL, MHC-I and -II binders). Most decisively, potentially efficient therapeutic regimens targeting different NiV proteins and genes were anticipated and projected. We hope this computational resource would be helpful in developing combating strategies against this deadly pathogen. Database URL: http://bioinfo.imtech.res.in/manojk/nipahvr/.
Related Papers
- → Reverse vaccinology, a genome-based approach to vaccine development(2001)490 cited
- → Two years into reverse vaccinology(2003)152 cited
- → Reverse Vaccinology and Vaccines for Serogroup B Neisseria meningitidis(2007)57 cited
- → Fine specificity of the B-cell epitopes recognized in HIV-1 NEF by human sera(1992)6 cited
- → Application of reverse vaccinology in vaccine research and development of infectious diseases(2008)